Handelsbanken Fonder AB / NBIX
Handelsbanken Fonder AB’s Neurocrine Biosciences Inc Position
Does Handelsbanken Fonder AB own Neurocrine Biosciences Inc (NBIX)? Yes — 187.9K shares worth $25M (+0.08% of its 13F portfolio) as of Q1 2026, down from 200.9K shares the prior filed quarter.
Position Value
$25M
Q1 2026
Shares
187.9K
% of Portfolio
+0.08%
Quarters Held
29
currently held
Position History NBIX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 187.9K | $25M | +0.08% |
| Q4 2025 | 200.9K | $28M | +0.09% |
| Q3 2025 | 109.5K | $15M | +0.05% |
| Q2 2025 | 104.0K | $13M | +0.05% |
| Q1 2025 | 86.1K | $10M | +0.04% |
| Q4 2024 | 26.9K | $4M | +0.01% |
| Q3 2024 | 26.9K | $3M | +0.01% |
| Q2 2024 | 22.3K | $3M | +0.01% |
| Q1 2024 | 23.1K | $3M | +0.01% |
| Q4 2023 | 18.9K | $2M | +0.01% |
| Q3 2023 | 17.4K | $2M | +0.01% |
| Q2 2023 | 17.4K | $2M | +0.01% |
| Q1 2023 | 17.6K | $2M | +0.01% |
| Q4 2022 | 13.2K | $2M | +0.01% |
| Q3 2022 | 15.3K | $2M | +0.01% |
| Q2 2022 | 15.3K | $1M | +0.01% |
| Q1 2022 | 15.3K | $1M | +0.01% |
| Q4 2021 | 10.2K | $866,000 | 0.00% |
| Q3 2021 | 17.5K | $2M | +0.01% |
| Q2 2021 | 17.5K | $2M | +0.01% |
| Q1 2021 | 18.1K | $2M | +0.01% |
| Q4 2020 | 18.1K | $2M | +0.01% |
| Q3 2020 | 220.0K | $21M | +0.15% |
| Q2 2020 | 399.9K | $49M | +0.21% |
| Q1 2020 | 204.0K | $18M | +0.38% |
| Q4 2019 | 169.0K | $18M | +0.31% |
| Q3 2019 | 204.0K | $18M | +0.37% |
| Q2 2019 | 177.0K | $15M | +0.28% |
| Q1 2019 | 207.0K | $18M | +0.35% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Handelsbanken Fonder AB’s full portfolio or all institutional holders of NBIX.